Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 23, 17:00
2565.45
12.75 (0.5%)
VOLUME 15,793
LIVE
NSE
Apr 23, 15:58
2565.90
13.3 (0.52%)
VOLUME 650,619
News on Dr Reddys Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's launches fenofibrate capsules

10.40 am | 23 Apr 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched Fenofibrate Capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of ANTARA capsules, in the US...

Nischal Maheshwari neutral on pharmaceutical space 

2.42 pm | 21 Apr 2014 |  Source: CNBC-TV18

Nischal Maheshwari of Edelweiss Financial Services is neutral on pharmaceutical space....

Break above 6828 could lift Nifty to 6910 in 4-5 days: Shah

1.18 pm | 21 Apr 2014 |  Source: Moneycontrol.com

Nifty is bound in a trading range of 6675-6828 points and many people will interpret this as a head and shoulder pattern, albeit a short term topping ...

Glenmark pulls 2,900 bottles of ulcer drug in US

2.32 pm | 18 Apr 2014 |  Source: Reuters

Medicines produced in India, which supplies about 40 percent of generic and over-the-counter drugs sold in the United States, have come under increase...

Dr Reddy's launches Eszopiclone Tablets C-IV

10.18 am | 16 Apr 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched Eszopiclone Tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA tablets C-IV ...

Lupin pulls over 9,000 bottles of anti-infective Suprax

2.16 pm | 15 Apr 2014 |  Source: Reuters

The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year b...

Religare expects Q4 to be mixed-bag, picks top sector bets 

11.56 am | 12 Apr 2014 |  Source: CNBC-TV18

Tirthankar Patnaik bearish on financials and public sector lenders, but State Bank of India is the stock from the PSB pack which he likes....

Dr Reddys Labs: FY14 results on May 13, 2014

8.40 pm | 11 Apr 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories board meeting will be held on May 13, 2014, to consider and approve the Audited Financial Results of the Company for the financ...

Pharma cos may see healthy earnings growth in Q4FY14: CLSA

12.36 pm | 03 Apr 2014 |  Source: Moneycontrol.com

Most companies are expected to report some forex gains on hedges and foreign liabilities given the slight strengthening of rupee Q-o-Q, CLSA said....

Super Six: Top chart picks for today 

8.33 am | 02 Apr 2014 |  Source: CNBC-TV18

Shrikant Chouhan of Kotak Securities advises buying Tata Motors with a target of Rs 410-415 and Dr Reddy's Laboratories with a target of Rs 2660-2670....

Exit Dr Reddy's Laboratories, says Kunal Bothra 

4.39 pm | 31 Mar 2014 |  Source: CNBC-TV18

Kunal Bothra, head of advisory at LKP advises exiting Dr Reddy's Laboratories....

Stocks in news: Sun Pharma, Unitech, Suzlon, Tech Mah, PNB

8.26 am | 28 Mar 2014 |  Source: CNBC-TV18

Sun Pharma | Colgate Palmolive | Canara Bank | Infosys | MCX | Lakshmi Vilas Bank | Unitech | Punjab National Bank | Claris Life Sciences | Godrej Pro...

Dr Reddy's launches generic cholesterol-lowering drug in US

6.59 pm | 27 Mar 2014 |  Source: PTI

The company's product is the generic equivalent of Pfizer Inc's Caduet tablets, it added. The Hyderabad-based firm's Amlodipine Besylate and Atorvasta...

Dr Reddys launched Amlodipine Besylate and Atorvastatin calcium tablets

10.22 am | 27 Mar 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched Amlodipine Besylate and Atorvastatin Calcium Tablets, a therapeutic equivalent generic version of CADUET tablets, ...

Here’s how market performed during UPA-2 regime 

10.37 pm | 26 Mar 2014 |  Source: CNBC-TV18

Since the UPA-2 came to power, wealth creation on the NSE stands at 35 lakh crore rupees with the nifty gaining 80 percent. But in dollar terms, that'...

India generic drugmakers' woes put new focus on quality

8.42 am | 26 Mar 2014 |  Source: Reuters

In the short term, that is expected to benefit larger global competitors, such as Teva Pharmaceutical Industries Ltd, Actavis Plc and Mylan Inc, which...

Buy Dr Reddys Laboratories; target Rs 3180: Motilal Oswal

5.15 pm | 12 Mar 2014 |  Source: Moneycontrol.com

Brokerage house Motilal Oswal is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 3180, in its ...

Buy Dr Reddys Laboratories; target of Rs 3239: ICICIdirect

2.56 pm | 06 Mar 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Dr Reddys Laboratories (DRL) and has recommended buy rating on the stock with a target price of Rs 3239, in its research...

Buy Dr Reddys Laboratories; target of Rs 2995: ICICIdirect

12.57 pm | 17 Feb 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 2995, in its research repor...

How experts are reading Dr Reddy's Laboratories Q3 results 

3.32 pm | 11 Feb 2014 |  Source: CNBC-TV18

Q3 earnings have been broadly in line with our expectation. We were expecting good traction in bot Russia and America as they have been key drivers fo...

1 2
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.